Upadacitinib is a selective JAK inhibitor under the development of AbbVie.ABT-494 is nearly 74 fold selective for Jak1 over Jak2 in cellular assays dependent on specific, relevant cytokines.
This report contains market size and forecasts of Upadacitinib in global, including the following market information:
Global Upadacitinib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Upadacitinib Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Upadacitinib companies in 2021 (%)
The global Upadacitinib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Upadacitinib include Cayman Chemical, BOC Sciences, Toronto Research Chemicals, AbMole, BioVision, Selleck Chemicals, TargetMol, Adooq Bioscience and Clearsynth, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Upadacitinib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Upadacitinib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Upadacitinib Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Upadacitinib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Upadacitinib Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Upadacitinib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Upadacitinib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Upadacitinib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Upadacitinib revenues share in global market, 2021 (%)
Key companies Upadacitinib sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Upadacitinib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cayman Chemical
BOC Sciences
Toronto Research Chemicals
AbMole
BioVision
Selleck Chemicals
TargetMol
Adooq Bioscience
Clearsynth
Taiclone
CSNpharm
MedKoo
AA BLOCKS
Ark Pharm